Hiroyuki Oshiumi mainly investigates Toll-like receptor, Molecular biology, Cell biology, RNA and RIG-I. His Toll-like receptor research incorporates elements of Interferon, Cancer research and Homology. Within one scientific family, Hiroyuki Oshiumi focuses on topics pertaining to TIRAP under Interferon, and may sometimes address concerns connected to Enzyme-linked receptor and Myeloid Differentiation Factor 88.
His Molecular biology study combines topics from a wide range of disciplines, such as Signal transduction, Kinase, Activator and IRF3. He interconnects Homologous recombination, Mre11 complex, DNA repair, Interferon regulatory factors and Nuclease in the investigation of issues within Cell biology. Hiroyuki Oshiumi works mostly in the field of RIG-I, limiting it down to concerns involving Ubiquitin ligase and, occasionally, Type I interferon production, Repressor, Innate immune system and Virology.
Hiroyuki Oshiumi mostly deals with Cell biology, Interferon, Innate immune system, Immunology and Virology. Hiroyuki Oshiumi has included themes like TRIF, Receptor, RNA silencing, TLR3 and MDA5 in his Cell biology study. His Interferon research is multidisciplinary, incorporating elements of Cancer research, Toll-like receptor, RNA, Intrinsic immunity and Molecular biology.
His research investigates the connection between Toll-like receptor and topics such as Gene that intersect with issues in Cell culture. The study incorporates disciplines such as Amino acid, Signal transduction, Signal transducing adaptor protein, Phosphorylation and Peptide sequence in addition to Molecular biology. His work deals with themes such as Microvesicles, Virus and Ubiquitin, Ubiquitin ligase, which intersect with Innate immune system.
The scientist’s investigation covers issues in Cell biology, Innate immune system, Immunology, Interferon and MDA5. His studies in Cell biology integrate themes in fields like RIG-I, TRIM25, Ubiquitin, Receptor and TLR3. His study in Innate immune system is interdisciplinary in nature, drawing from both Microvesicles, Virus, Dendritic cell and RNA silencing.
Interferon is the subject of his research, which falls under Virology. The various areas that he examines in his MDA5 study include Signal transduction, Gene knockdown and Mitochondrial antiviral-signaling protein. His study connects Molecular biology and RNA.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
Hiroyuki Oshiumi;Misako Matsumoto;Kenji Funami;Takashi Akazawa.
Nature Immunology (2003)
Subcellular Localization of Toll-Like Receptor 3 in Human Dendritic Cells
Misako Matsumoto;Kenji Funami;Masako Tanabe;Hiroyuki Oshiumi.
Journal of Immunology (2003)
TIR-containing Adapter Molecule (TICAM)-2, a Bridging Adapter Recruiting to Toll-like Receptor 4 TICAM-1 That Induces Interferon-β
Hiroyuki Oshiumi;Miwa Sasai;Kyoko Shida;Takashi Fujita.
Journal of Biological Chemistry (2003)
Complex Formation and Functional Versatility of Mre11 of Budding Yeast in Recombination
Takehiko Usui;Tsutomu Ohta;Hiroyuki Oshiumi;Hiroyuki Oshiumi;Jun-ichi Tomizawa.
Cell (1998)
Riplet/RNF135, a RING Finger Protein, Ubiquitinates RIG-I to Promote Interferon-β Induction during the Early Phase of Viral Infection
Hiroyuki Oshiumi;Misako Matsumoto;Shigetsugu Hatakeyama;Tsukasa Seya.
Journal of Biological Chemistry (2009)
Teleost TLR22 recognizes RNA duplex to induce IFN and protect cells from birnaviruses.
Aya Matsuo;Hiroyuki Oshiumi;Tadayuki Tsujita;Hiroshi Mitani.
Journal of Immunology (2008)
Prediction of the prototype of the human Toll-like receptor gene family from the pufferfish, Fugu rubripes, genome
Hiroyuki Oshiumi;Tadayuki Tsujita;Kyoko Shida;Misako Matsumoto.
Immunogenetics (2003)
Toll-like receptor 3: a link between toll-like receptor, interferon and viruses.
Misako Matsumoto;Kenji Funami;Hiroyuki Oshiumi;Tsukasa Seya.
Microbiology and Immunology (2004)
The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection.
Hiroyuki Oshiumi;Moeko Miyashita;Naokazu Inoue;Masaru Okabe.
Cell Host & Microbe (2010)
DDX60, a DEXD/H Box Helicase, Is a Novel Antiviral Factor Promoting RIG-I-Like Receptor-Mediated Signaling
Moeko Miyashita;Hiroyuki Oshiumi;Misako Matsumoto;Tsukasa Seya.
Molecular and Cellular Biology (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Hokkaido University
Aomori University
Osaka University
Kumamoto University
Osaka University
Okayama University
Hokkaido University
Tokyo Metropolitan Institute of Medical Science
National Institutes of Health
Hokkaido University
American University of Sharjah
Pennsylvania State University
Feng Chia University
Kyushu University
University of Genoa
Goethe University Frankfurt
National Institutes of Health
University of Iowa
McMaster University
University of Murcia
Johns Hopkins University
Retina Foundation of the Southwest
University of British Columbia
University of North Texas
Boston University
University of California, Berkeley